Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Ann Oncol ; 2(6): 417-22, 1991 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-1768628

RESUMO

The psychometric characteristics of two indexes used to evaluate the subjective morbidity of chemotherapy regimens were analyzed. Both indexes assessed the duration of discomfort as perceived by the patient throughout therapy. The first index asked patients to state the number of days spent with 'discomfort', and the second index asked them which days they would like to eliminate altogether because of the unbearable symptoms experienced on those days. While the first index gives some idea of the duration of suffering, without defining it, the second highlights a specific time when the quality of her life was unacceptable to the patient. We studied these indexes in the form of a questionnaire completed by 168 women who had entered a cancer clinical trial. This trial evaluated the efficacy of primary chemotherapy in rendering conservative surgery feasible in women with operable breast cancer, but whose tumor size was greater than 3 cm. Four different treatment regimens were used: CMF, FAC, FEC, FNC (C = cyclophosphamide, M = methotrexate, F = fluorouracil, A = adriamycin, E = epirubicin, N = mitoxantrone). Seventy-nine patients were interviewed during chemotherapy and 89 during follow-up visits. Initial assessment of the reliability, discriminant and concurrent validity of the two indexes produced satisfactory results. Finally, we analyzed the responses given by 168 patients for a total of 600 treatment cycles. The average value of 'discomfort' was 3 days, whereas the average value of days 'to be eliminated' was 1. The range of subjective morbidity (for every cycle of treatment: 'discomfort = 0-30 days; 'to be eliminated' = 0-20 days) was very broad.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Qualidade de Vida , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Neoplasias da Mama/cirurgia , Quimioterapia Adjuvante , Ciclofosfamida/administração & dosagem , Análise Discriminante , Doxorrubicina/administração & dosagem , Epirubicina/administração & dosagem , Feminino , Fluoruracila/administração & dosagem , Humanos , Metástase Linfática , Metotrexato/administração & dosagem , Pessoa de Meia-Idade , Mitoxantrona/administração & dosagem , Reprodutibilidade dos Testes , Inquéritos e Questionários
2.
Minerva Psichiatr ; 31(4): 203-7, 1990.
Artigo em Italiano | MEDLINE | ID: mdl-2096270

RESUMO

The Maslach Burn Out Inventory (1981) has been applied to a group of workers at three Psychosocial Centres at Milan and Trieste characterised by differing work styles. Point scores were related to a number of variables relative to the professional situation and work organisation. The same scores were related to the results of a questionnaire (Contessa 1987) on the operator's perception of his activity and on motivational factors with respect to the professional choice in actuality and at the beginning of the career. It was therefore possible to identify a set of positive correlations that indicate the presence of factors which increase or reduce B.O. Level.


Assuntos
Esgotamento Profissional/psicologia , Hospitais Especializados , Humanos , Itália , Fatores de Risco , Apoio Social
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA